LINC-ROR and breast cancer: The overexpression of miR‐194‐3p increased the sensitivity of breast cancer cells to rapamycin, thus reducing cell viability in the presence of rapamycin, and the rescued miR‐194‐3p expression reduced the linc‐ROR‐mediated decrease in the sensitivity of breast cancer cells to rapamycin (Fig. 11A).